Literature DB >> 16763248

What is the optimal duration of antibiotic therapy?

John Paul1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16763248      PMCID: PMC1476722          DOI: 10.1136/bmj.332.7554.1358

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.

Authors:  Rachida el Moussaoui; Corianne A J M de Borgie; Peterhans van den Broek; Willem N Hustinx; Paul Bresser; Guido E L van den Berk; Jan-Werner Poley; Bob van den Berg; Frans H Krouwels; Marc J M Bonten; Carla Weenink; Patrick M M Bossuyt; Peter Speelman; Brent C Opmeer; Jan M Prins
Journal:  BMJ       Date:  2006-06-10

3.  Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2005-10       Impact factor: 2.129

4.  Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

Authors:  V G Fowler; L L Sanders; D J Sexton; L Kong; K A Marr; A K Gopal; G Gottlieb; R S McClelland; G R Corey
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

  4 in total
  4 in total

1.  A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection.

Authors:  Antonio Basoli; Piero Chirletti; Ercole Cirino; Nicola G D'Ovidio; Giovanni Battista Doglietto; Domenico Giglio; Stefano M Giulini; Alberto Malizia; Mario Taffurelli; Jelena Petrovic; Maurizio Ecari
Journal:  J Gastrointest Surg       Date:  2007-09-11       Impact factor: 3.452

2.  Novel purification method and antibiotic activity of recombinant Momordica charantia MAP30.

Authors:  Ching-Dong Chang; Ping-Yuan Lin; Yo-Chia Chen; Han-Hsiang Huang; Wen-Ling Shih
Journal:  3 Biotech       Date:  2017-04-07       Impact factor: 2.406

3.  Usage patterns of carbapenem antimicrobials in dogs and cats at a veterinary tertiary care hospital.

Authors:  Alison Smith; Annie S Wayne; Claire L Fellman; Marieke H Rosenbaum
Journal:  J Vet Intern Med       Date:  2019-05-22       Impact factor: 3.333

4.  Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria.

Authors:  Uri Obolski; Lilach Hadany
Journal:  BMC Med       Date:  2012-08-13       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.